The Experts below are selected from a list of 3282 Experts worldwide ranked by ideXlab platform
Freddy Penninckx - One of the best experts on this subject based on the ideXlab platform.
-
outpatient laparoscopic cholecystectomy clinical pathway implementation is efficient and cost effective and increases Hospital Bed Capacity
Surgical Endoscopy and Other Interventional Techniques, 2007Co-Authors: Baki Topal, G Peeters, A Verbert, Freddy PenninckxAbstract:Background Outpatient laparoscopic cholecystectomy (OLC) may decrease the use of Hospital resources and save costs. In the current study, the effect of implementing a clinical pathway has been assessed in terms of outcome for patients scheduled to undergo laparoscopic cholecystectomy, Hospital costs, and available Bed Capacity.
-
outpatient laparoscopic cholecystectomy clinical pathway implementation is efficient and cost effective and increases Hospital Bed Capacity
Surgical Endoscopy and Other Interventional Techniques, 2007Co-Authors: Baki Topal, G Peeters, A Verbert, Freddy PenninckxAbstract:Outpatient laparoscopic cholecystectomy (OLC) may decrease the use of Hospital resources and save costs. In the current study, the effect of implementing a clinical pathway has been assessed in terms of outcome for patients scheduled to undergo laparoscopic cholecystectomy, Hospital costs, and available Bed Capacity. Clinical outcome and Hospital stay were analyzed for consecutive patients scheduled to undergo laparoscopic cholecystectomy 1 year before (n = 338) and after (n = 336) implementation of a clinical pathway. Patients with acute cholecystitis or bile duct lithiasis were excluded from the study. A cost accounting model was developed using the concept of the bill of activities. Before implementation of the clinical pathway, 34 (94%) of 36 patients scheduled for OLC were discharged successfully on the day of surgery, as compared with 110 (94%) of 117 patients after pathway implementation. Among patients scheduled for OLC, the complication (0% vs 1.7%), unplanned admission (5.5% vs 6%), and readmission (0% vs 4.3%) rates were comparable before and after clinical pathway implementation. After pathway implementation, the increased number of OLCs resulted in a significant cost saving (40.5%) and benefit in Bed Capacity (1.41 Beds per day per year) for the Hospital. The implementation of a clinical pathway preserves the clinical outcome for patients undergoing OLC. It creates a significant increase in the number of patients treated in an outpatient setting and confers a significant benefit in terms of Hospital costs and available Bed Capacity.
Baki Topal - One of the best experts on this subject based on the ideXlab platform.
-
outpatient laparoscopic cholecystectomy clinical pathway implementation is efficient and cost effective and increases Hospital Bed Capacity
Surgical Endoscopy and Other Interventional Techniques, 2007Co-Authors: Baki Topal, G Peeters, A Verbert, Freddy PenninckxAbstract:Background Outpatient laparoscopic cholecystectomy (OLC) may decrease the use of Hospital resources and save costs. In the current study, the effect of implementing a clinical pathway has been assessed in terms of outcome for patients scheduled to undergo laparoscopic cholecystectomy, Hospital costs, and available Bed Capacity.
-
outpatient laparoscopic cholecystectomy clinical pathway implementation is efficient and cost effective and increases Hospital Bed Capacity
Surgical Endoscopy and Other Interventional Techniques, 2007Co-Authors: Baki Topal, G Peeters, A Verbert, Freddy PenninckxAbstract:Outpatient laparoscopic cholecystectomy (OLC) may decrease the use of Hospital resources and save costs. In the current study, the effect of implementing a clinical pathway has been assessed in terms of outcome for patients scheduled to undergo laparoscopic cholecystectomy, Hospital costs, and available Bed Capacity. Clinical outcome and Hospital stay were analyzed for consecutive patients scheduled to undergo laparoscopic cholecystectomy 1 year before (n = 338) and after (n = 336) implementation of a clinical pathway. Patients with acute cholecystitis or bile duct lithiasis were excluded from the study. A cost accounting model was developed using the concept of the bill of activities. Before implementation of the clinical pathway, 34 (94%) of 36 patients scheduled for OLC were discharged successfully on the day of surgery, as compared with 110 (94%) of 117 patients after pathway implementation. Among patients scheduled for OLC, the complication (0% vs 1.7%), unplanned admission (5.5% vs 6%), and readmission (0% vs 4.3%) rates were comparable before and after clinical pathway implementation. After pathway implementation, the increased number of OLCs resulted in a significant cost saving (40.5%) and benefit in Bed Capacity (1.41 Beds per day per year) for the Hospital. The implementation of a clinical pathway preserves the clinical outcome for patients undergoing OLC. It creates a significant increase in the number of patients treated in an outpatient setting and confers a significant benefit in terms of Hospital costs and available Bed Capacity.
G Peeters - One of the best experts on this subject based on the ideXlab platform.
-
outpatient laparoscopic cholecystectomy clinical pathway implementation is efficient and cost effective and increases Hospital Bed Capacity
Surgical Endoscopy and Other Interventional Techniques, 2007Co-Authors: Baki Topal, G Peeters, A Verbert, Freddy PenninckxAbstract:Background Outpatient laparoscopic cholecystectomy (OLC) may decrease the use of Hospital resources and save costs. In the current study, the effect of implementing a clinical pathway has been assessed in terms of outcome for patients scheduled to undergo laparoscopic cholecystectomy, Hospital costs, and available Bed Capacity.
-
outpatient laparoscopic cholecystectomy clinical pathway implementation is efficient and cost effective and increases Hospital Bed Capacity
Surgical Endoscopy and Other Interventional Techniques, 2007Co-Authors: Baki Topal, G Peeters, A Verbert, Freddy PenninckxAbstract:Outpatient laparoscopic cholecystectomy (OLC) may decrease the use of Hospital resources and save costs. In the current study, the effect of implementing a clinical pathway has been assessed in terms of outcome for patients scheduled to undergo laparoscopic cholecystectomy, Hospital costs, and available Bed Capacity. Clinical outcome and Hospital stay were analyzed for consecutive patients scheduled to undergo laparoscopic cholecystectomy 1 year before (n = 338) and after (n = 336) implementation of a clinical pathway. Patients with acute cholecystitis or bile duct lithiasis were excluded from the study. A cost accounting model was developed using the concept of the bill of activities. Before implementation of the clinical pathway, 34 (94%) of 36 patients scheduled for OLC were discharged successfully on the day of surgery, as compared with 110 (94%) of 117 patients after pathway implementation. Among patients scheduled for OLC, the complication (0% vs 1.7%), unplanned admission (5.5% vs 6%), and readmission (0% vs 4.3%) rates were comparable before and after clinical pathway implementation. After pathway implementation, the increased number of OLCs resulted in a significant cost saving (40.5%) and benefit in Bed Capacity (1.41 Beds per day per year) for the Hospital. The implementation of a clinical pathway preserves the clinical outcome for patients undergoing OLC. It creates a significant increase in the number of patients treated in an outpatient setting and confers a significant benefit in terms of Hospital costs and available Bed Capacity.
A Verbert - One of the best experts on this subject based on the ideXlab platform.
-
outpatient laparoscopic cholecystectomy clinical pathway implementation is efficient and cost effective and increases Hospital Bed Capacity
Surgical Endoscopy and Other Interventional Techniques, 2007Co-Authors: Baki Topal, G Peeters, A Verbert, Freddy PenninckxAbstract:Background Outpatient laparoscopic cholecystectomy (OLC) may decrease the use of Hospital resources and save costs. In the current study, the effect of implementing a clinical pathway has been assessed in terms of outcome for patients scheduled to undergo laparoscopic cholecystectomy, Hospital costs, and available Bed Capacity.
-
outpatient laparoscopic cholecystectomy clinical pathway implementation is efficient and cost effective and increases Hospital Bed Capacity
Surgical Endoscopy and Other Interventional Techniques, 2007Co-Authors: Baki Topal, G Peeters, A Verbert, Freddy PenninckxAbstract:Outpatient laparoscopic cholecystectomy (OLC) may decrease the use of Hospital resources and save costs. In the current study, the effect of implementing a clinical pathway has been assessed in terms of outcome for patients scheduled to undergo laparoscopic cholecystectomy, Hospital costs, and available Bed Capacity. Clinical outcome and Hospital stay were analyzed for consecutive patients scheduled to undergo laparoscopic cholecystectomy 1 year before (n = 338) and after (n = 336) implementation of a clinical pathway. Patients with acute cholecystitis or bile duct lithiasis were excluded from the study. A cost accounting model was developed using the concept of the bill of activities. Before implementation of the clinical pathway, 34 (94%) of 36 patients scheduled for OLC were discharged successfully on the day of surgery, as compared with 110 (94%) of 117 patients after pathway implementation. Among patients scheduled for OLC, the complication (0% vs 1.7%), unplanned admission (5.5% vs 6%), and readmission (0% vs 4.3%) rates were comparable before and after clinical pathway implementation. After pathway implementation, the increased number of OLCs resulted in a significant cost saving (40.5%) and benefit in Bed Capacity (1.41 Beds per day per year) for the Hospital. The implementation of a clinical pathway preserves the clinical outcome for patients undergoing OLC. It creates a significant increase in the number of patients treated in an outpatient setting and confers a significant benefit in terms of Hospital costs and available Bed Capacity.
Peter J Wijkstra - One of the best experts on this subject based on the ideXlab platform.
-
a randomized trial of initiation of chronic noninvasive mechanical ventilation at home vs in Hospital in patients with neuromuscular disease and thoracic cage disorder the dutch homerun trial
Chest, 2020Co-Authors: Ries J M Van Den Biggelaar, Anda Hazenberg, N A M Cobben, Michael A Gaytant, Karin M Vermeulen, Peter J WijkstraAbstract:BACKGROUND There is an increasing demand for home mechanical ventilation (HMV) in patients with chronic respiratory insufficiency. At present, noninvasive ventilation is exclusively initiated in a clinical setting at all four centers for HMV in the Netherlands. In addition to its high societal costs and patient discomfort, commencing HMV is often delayed because of a lack of Hospital Bed Capacity. RESEARCH QUESTION Is HMV initiation at home, using a telemonitoring approach, noninferior to in-Hospital initiation in a nationwide study? STUDY DESIGN AND METHODS We conducted a nationwide, randomized controlled noninferiority trial, in which every HMV center recruited 24 patients (home [n = 12] vs Hospital [n = 12]) with a neuromuscular disease or thoracic cage disorder, all with an indication to start HMV. Change in arterial CO2 (Paco2) over a 6-month period was considered the primary outcome, and quality of life and costs were assessed as secondary outcomes. RESULTS A total of 96 patients were randomized, most of them diagnosed with neuromuscular disease. We found a significant improvement in Paco2 within both groups (home: from 6.1 to 5.6 kPa [P < .01]; Hospital: from 6.3 to 5.6 kPa [P < .01]), with no significant differences between groups. Health-related quality of life showed significant improvement on various subscales; however, no significant differences were observed between the home and Hospital groups. From a societal perspective, a cost reduction of more than €3,200 ($3,793) per patient was evident in the home group. INTERPRETATION This nationwide, multicenter study shows that HMV initiation at home is noninferior to Hospital initiation, as it shows the same improvement in gas exchange and health-related quality of life. In fact, from a patient's perspective, it might even be a more attractive approach. In addition, starting at home saves over €3,200 ($3,793) per patient over a 6-month period. TRIAL REGISTRY ClinicalTrials.gov; No.: NCT03203577; URL: www.clinicaltrials.gov.